Sfoglia per Rivista ALIMENTARY PHARMACOLOGY
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply
2020-01-01 Sands, Bruce E; Armuzzi, Alessandro; Marshall, John K; Lindsay, James O; Sandborn, William J; Danese, Silvio; Panés, Julián; Bressler, Brian; Colombel, Jean-Frédéric; Lawendy, Nervin; Maller, Eric; Zhang, Haiying; Chan, Gary; Salese, Leonardo; Tsilkos, Konstantinos; Marren, Amy; Su, Chinyu
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines
2014-01-01 Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients
2017-01-01 Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S
Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation
2013-01-01 Indriolo, A; Fagiuoli, S; Pasulo, L; Fiorino, G; Danese, S; Ravelli, P
Letter: Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication—a retrospective multicentre-cohort analysis. Authors' reply
2023-01-01 Piovani, D.; Tsantes, A. G.; Schunemann, H. J.; Bonovas, S.
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma
2024-01-01 De , ; Toni Enrico, N; Mayerle, Julia; Oehrle, Bettina; Seidensticker, Max; Rimassa, Lorenza; Philipp, Alexander; Roessler, Daniel; Khaled Najib, Ben.
Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy
2021-01-01 Privitera, G; Pugliese, D; Scaldaferri, F; Armuzzi, A
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply
2020-01-01 Sandborn, William J; Panés, Julian; Sands, Bruce E; Reinisch, Walter; Su, Chinyu; Lawendy, Nervin; Koram, Nana; Fan, Haiyun; Jones, Thomas V; Modesto, Irene; Quirk, Daniel; Danese, Silvio
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease
2016-01-01 Fraquelli, M.; Baccarin, A.; Casazza, G.; Conti, C. B.; Giunta, M.; Massironi, S.; Invernizzi, F.; Donato, M. F.; Maggioni, M.; Aghemo, A.; Conte, D.; Colombo, M.
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates
2000-01-01 Canducci, F; Armuzzi, A; Cremonini, F; Cammarota, G; Bartolozzi, F; Pola, P; Gasbarrini, G; Gasbarrini, A
Meta-analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression
2023-01-01 Piovani, Daniele; Tsantes, Andreas G; Schunemann, Holger J; Bonovas, Stefanos
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population
2003-01-01 Leong, Rwl; Armuzzi, A; Ahmad, T; Wong, Ml; Tse, P; Jewell, Dp; Sung, Jjy
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease
2011-01-01 Savarino, E.; Gemignani, L.; Pohl, D.; Zentilin, P.; Dulbecco, P.; Assandri, L.; Marabotto, E.; Bonfanti, D.; Inferrera, S.; Fazio, V.; Malesci, A.; Tutuian, R.; Savarino, V.
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin
1998-01-01 Cammarota, G; Cannizzaro, O; Tursi, A; Papa, A; Gasbarrini, A; Cuoco, L; Cianei, R; Armuzzi, A; Fedeli, P; Fedeli, G; Gasbarrini, G
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
2015-01-01 Pugliese, D; Guidi, L; Ferraro, Pm; Marzo, M; Felice, C; Celleno, L; Landi, R; Andrisani, G; Pizzolante, F; De Vitis, I; Papa, A; Rapaccini, Gl; Armuzzi, A
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey
2018-01-01 Olivera, P; Sandborn, Wj; Panes, J; Baumann, C; D'Haens, G; Vermeire, S; Danese, S; Peyrin-Biroulet, L
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy
2007-01-01 Zullo, A; Perna, Francesco; Hassan, Cesare; Ricci, C; Saracino, I; Morini, S; Vaira, D.
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction
2006-01-01 De Francesco, V; Margiotta, M; Zullo, A; Hassan, Cesare; Valle, Nd; Burattini, O; Cea, U; Stoppino, G; Amoruso, A; Stella, F; Morini, S; Panella, C; Ierardi, E.
Proton-pump inhibitor for peptic ulcer bleeding
2005-01-01 Zullo, A; Hassan, Cesare; Morini, S.
Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations
2012-01-01 Repici, A; Cestari, R; Annese, V; Biscaglia, G; Vitetta, E; Minelli, L; Trallori, G; Orselli, S; Andriulli, A; Hassan, C
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply | 1-gen-2020 | Sands, Bruce E; Armuzzi, Alessandro; Marshall, John K; Lindsay, James O; Sandborn, William J; Danese, Silvio; Panés, Julián; Bressler, Brian; Colombel, Jean-Frédéric; Lawendy, Nervin; Maller, Eric; Zhang, Haiying; Chan, Gary; Salese, Leonardo; Tsilkos, Konstantinos; Marren, Amy; Su, Chinyu | |
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines | 1-gen-2014 | Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W | |
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients | 1-gen-2017 | Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martinez, A; Danese, S | |
Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation | 1-gen-2013 | Indriolo, A; Fagiuoli, S; Pasulo, L; Fiorino, G; Danese, S; Ravelli, P | |
Letter: Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication—a retrospective multicentre-cohort analysis. Authors' reply | 1-gen-2023 | Piovani, D.; Tsantes, A. G.; Schunemann, H. J.; Bonovas, S. | |
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma | 1-gen-2024 | De , ; Toni Enrico, N; Mayerle, Julia; Oehrle, Bettina; Seidensticker, Max; Rimassa, Lorenza; Philipp, Alexander; Roessler, Daniel; Khaled Najib, Ben. | |
Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy | 1-gen-2021 | Privitera, G; Pugliese, D; Scaldaferri, F; Armuzzi, A | |
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply | 1-gen-2020 | Sandborn, William J; Panés, Julian; Sands, Bruce E; Reinisch, Walter; Su, Chinyu; Lawendy, Nervin; Koram, Nana; Fan, Haiyun; Jones, Thomas V; Modesto, Irene; Quirk, Daniel; Danese, Silvio | |
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease | 1-gen-2016 | Fraquelli, M.; Baccarin, A.; Casazza, G.; Conti, C. B.; Giunta, M.; Massironi, S.; Invernizzi, F.; Donato, M. F.; Maggioni, M.; Aghemo, A.; Conte, D.; Colombo, M. | |
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates | 1-gen-2000 | Canducci, F; Armuzzi, A; Cremonini, F; Cammarota, G; Bartolozzi, F; Pola, P; Gasbarrini, G; Gasbarrini, A | |
Meta-analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression | 1-gen-2023 | Piovani, Daniele; Tsantes, Andreas G; Schunemann, Holger J; Bonovas, Stefanos | |
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population | 1-gen-2003 | Leong, Rwl; Armuzzi, A; Ahmad, T; Wong, Ml; Tse, P; Jewell, Dp; Sung, Jjy | |
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease | 1-gen-2011 | Savarino, E.; Gemignani, L.; Pohl, D.; Zentilin, P.; Dulbecco, P.; Assandri, L.; Marabotto, E.; Bonfanti, D.; Inferrera, S.; Fazio, V.; Malesci, A.; Tutuian, R.; Savarino, V. | |
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin | 1-gen-1998 | Cammarota, G; Cannizzaro, O; Tursi, A; Papa, A; Gasbarrini, A; Cuoco, L; Cianei, R; Armuzzi, A; Fedeli, P; Fedeli, G; Gasbarrini, G | |
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study | 1-gen-2015 | Pugliese, D; Guidi, L; Ferraro, Pm; Marzo, M; Felice, C; Celleno, L; Landi, R; Andrisani, G; Pizzolante, F; De Vitis, I; Papa, A; Rapaccini, Gl; Armuzzi, A | |
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey | 1-gen-2018 | Olivera, P; Sandborn, Wj; Panes, J; Baumann, C; D'Haens, G; Vermeire, S; Danese, S; Peyrin-Biroulet, L | |
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy | 1-gen-2007 | Zullo, A; Perna, Francesco; Hassan, Cesare; Ricci, C; Saracino, I; Morini, S; Vaira, D. | |
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction | 1-gen-2006 | De Francesco, V; Margiotta, M; Zullo, A; Hassan, Cesare; Valle, Nd; Burattini, O; Cea, U; Stoppino, G; Amoruso, A; Stella, F; Morini, S; Panella, C; Ierardi, E. | |
Proton-pump inhibitor for peptic ulcer bleeding | 1-gen-2005 | Zullo, A; Hassan, Cesare; Morini, S. | |
Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations | 1-gen-2012 | Repici, A; Cestari, R; Annese, V; Biscaglia, G; Vitetta, E; Minelli, L; Trallori, G; Orselli, S; Andriulli, A; Hassan, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile